These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 51296)

  • 1. New drugs.
    Hunter AR
    Lancet; 1975 Sep; 2(7933):493-4. PubMed ID: 51296
    [No Abstract]   [Full Text] [Related]  

  • 2. Information contained in drug advertisements.
    Stimson GV
    Br Med J; 1975 Nov; 4(5995):508-9. PubMed ID: 1192148
    [No Abstract]   [Full Text] [Related]  

  • 3. Control of drugs.
    Br Med J; 1967 Sep; 3(5567):689-90. PubMed ID: 6038356
    [No Abstract]   [Full Text] [Related]  

  • 4. The extent of advertising of pharmaceutical products.
    Stimson GV
    J R Coll Gen Pract; 1976; 26 Suppl 1(Suppl 1):69-76. PubMed ID: 1011223
    [No Abstract]   [Full Text] [Related]  

  • 5. RECENT EXPERIENCES WITH EFFECTIVE NEW DRUG APPLICATIONS.
    MEYERS EL
    Bull Parenter Drug Assoc; 1964; 18():1-6. PubMed ID: 14224959
    [No Abstract]   [Full Text] [Related]  

  • 6. The food and Drug Administration's view of investigational drugs.
    MEYERS EL
    SD J Med Pharm; 1963 Jul; 16():40-6. PubMed ID: 13935340
    [No Abstract]   [Full Text] [Related]  

  • 7. RULES, REGULATIONS AND RESEARCH.
    NEIBEL OJ
    New Physician; 1963 Dec; 12():A85-A87. PubMed ID: 14103668
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical investigation of new drugs.
    Pugsley LI
    Appl Ther; 1966 Mar; 8(3):243-9. PubMed ID: 5324973
    [No Abstract]   [Full Text] [Related]  

  • 9. The evolution of new drug legislation.
    Kelsey FO
    BMQ; 1966 Sep; 17(3):72-81. PubMed ID: 5978212
    [No Abstract]   [Full Text] [Related]  

  • 10. [INSPECTION OF DRUGS].
    SIDERIUS P
    Tijdschr Soc Geneeskd; 1964 Jan; 42():4-8. PubMed ID: 14137283
    [No Abstract]   [Full Text] [Related]  

  • 11. THE INVESTIGATIONAL DRUG BRANCH: A REVIEW OF OBJECTIVES AND FUNCTION.
    KELSEY FO
    J New Drugs; 1963; 3(4):250-5. PubMed ID: 14063363
    [No Abstract]   [Full Text] [Related]  

  • 12. New laws on control of drugs?
    Lancet; 1967 Sep; 2(7516):601-2. PubMed ID: 4166834
    [No Abstract]   [Full Text] [Related]  

  • 13. New drugs and the Kefauver-Harris amendment.
    Krantz JC
    J New Drugs; 1966; 6(2):77-9. PubMed ID: 5917906
    [No Abstract]   [Full Text] [Related]  

  • 14. REGULATIONS AFFECTING DRUG RESEARCH AND DEVELOPMENT: A HISTORICAL PERSPECTIVE.
    KLUMPP TG
    J New Drugs; 1963; 3(4):212-20. PubMed ID: 14063357
    [No Abstract]   [Full Text] [Related]  

  • 15. [THE DRUG SUPPLY LAW].
    GOUDSMIT CJ
    Tijdschr Soc Geneeskd; 1964 Jan; 42():2-4. PubMed ID: 14137278
    [No Abstract]   [Full Text] [Related]  

  • 16. New drugs: the AMA and the FDA.
    Appel JZ
    Ann Allergy; 1966 Jul; 24(7):333-6. PubMed ID: 5941864
    [No Abstract]   [Full Text] [Related]  

  • 17. CONTROL OF DRUG TOXICITY IN THE UNITED STATES OF AMERICA.
    WESTON JK; WESTON K
    Practitioner; 1965 Jan; 194():16-21. PubMed ID: 14259685
    [No Abstract]   [Full Text] [Related]  

  • 18. NEW DRUG SURVEILLANCE IN 1964.
    ELLENHORN MJ
    Am J Pharm Sci Support Public Health; 1964; 136():114-27. PubMed ID: 14167236
    [No Abstract]   [Full Text] [Related]  

  • 19. Title XIX, the State Medical Journal and the pharmaceutical manufacturer.
    Warner RS
    Ohio State Med J; 1968 Jun; 64(6):674-8. PubMed ID: 5656667
    [No Abstract]   [Full Text] [Related]  

  • 20. THE PHYSICIAN AS FINAL ARBITER?
    PAGE I
    Appl Ther; 1964 Apr; 6():293-5. PubMed ID: 14152073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.